Liste des publications

Toutes les publications des équipes du C3M.

Exporter en CSV
Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease.

Auteurs Vazquez-Chantada M, Gonzalez-Lahera A, Martinez-Arranz I, Garcia-Monzon C, Regueiro MM, Garcia-Rodriguez JL, Schlangen KA, Mendibil I, Rodriguez-Ezpeleta N, Lozano JJ, Banasik K, Justesen JM, Joergensen T, Witte DR, Lauritzen T, Hansen T, Pedersen O, Veyrie N, Clement K, Tordjman J, Tran A, Le Marchand-Brustel Y, Buque X, Aspichueta P, Echevarria-Uraga JJ, Martin-Duce A, Caballeria J, Gual P, Castro A, Mato JM, Martinez-Chantar ML, Aransay AM

Hepatology (Baltimore, Md.) Feb 2013

How recent advances in high-risk myelodysplastic syndrome physiopathology may impact future treatments.

Auteurs Cluzeau T, Robert G, Jacquel A, Auberger P

Current pharmaceutical design Jan 2013

Melanoma: from melanocyte to genetic alterations and clinical options.

Auteurs Bertolotto C

Scientifica Jan 2013

Progress in understanding postnatal immune dysregulation in allergic disease.

Auteurs Prescott SL, Martino D, Hodder M, Richman T, Tulic MK

The World Allergy Organization journal Dec 2012

Regulated in development and DNA damage responses -1 (REDD1) protein contributes to insulin signaling pathway in adipocytes.

Auteurs Regazzetti C, Dumas K, Le Marchand-Brustel Y, Peraldi P, Tanti JF, Giorgetti-Peraldi S

PloS one Déc 2012

Simalikalactone E (SkE), a new weapon in the armamentarium of drugs targeting cancers that exhibit constitutive activation of the ERK pathway.

Auteurs Robert G, Jullian V, Jacquel A, Ginet C, Dufies M, Torino S, Pottier A, Peyrade F, Tartare-Deckert S, Bourdy G, Deharo E, Auberger P

Oncotarget Dec 2012

Autophagy, signaling and obesity.

Auteurs Lavallard VJ, Meijer AJ, Codogno P, Gual P

Pharmacological research Dec 2012

Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response.

Auteurs Bénéteau M, Zunino B, Jacquin MA, Meynet O, Chiche J, Pradelli LA, Marchetti S, Cornille A, Carles M, Ricci JE

Proceedings of the National Academy of Sciences of the United States of America Dec 2012

All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinib.

Auteurs Cassuto O, Dufies M, Jacquel A, Robert G, Ginet C, Dubois A, Hamouda A, Puissant A, Luciano F, Karsenti JM, Legros L, Cassuto JP, Lenain P, Auberger P

Oncotarget Dec 2012

DICER- and AGO3-dependent generation of retinoic acid-induced DR2 Alu RNAs regulates human stem cell proliferation.

Auteurs Hu Q, Tanasa B, Trabucchi M, Li W, Zhang J, Ohgi KA, Rose DW, Glass CK, Rosenfeld MG

Nature structural & molecular biology Nov 2012